Lindt und Sprungli
Note: This is a daily stock update and the information stands true as of 22/07/25, 09:00 CET.
Company Update:
Expert Opinion:
Lindt &Sprungli is a great company with strong brand loyalty and the ability to pass price increases. It is therefore a great defensive name. However, the price paid to own the shares today is far too expensive to our expert's liking. Stock trades on PE25 and 26 of 42.7x and 39.7x respectively, down to 36.4x in 2027. Furthermore, our expert fears that the final demand for chocolate and sweets will eventually be impacted by the increasing adoption of GLP1 drugs worldwide. He would definitely stay away from Lindt und Sprungli.
For daily updates, subscribe to our newsletter and for detailed information, reach out to us at sales@alphavalue.eu
Company Update:
H1 sales came in at CHF2350m, a slight beat vs estimates of CHF2298m. But while organic growth came in above (+11.5% vs 9.6% expected), the volumes were worse than expected with a 4.6% drop vs a 2.5% drop expected.
Therefore, EBIT was logically a 3% miss at CHF259m and net profit was a 5% miss at CHF189m
Lindt &Sprungli increased its FY organic growth in the 9-11% range vs 7-9% previously.
Lindt &Sprungli is a great company with strong brand loyalty and the ability to pass price increases. It is therefore a great defensive name. However, the price paid to own the shares today is far too expensive to our expert's liking. Stock trades on PE25 and 26 of 42.7x and 39.7x respectively, down to 36.4x in 2027. Furthermore, our expert fears that the final demand for chocolate and sweets will eventually be impacted by the increasing adoption of GLP1 drugs worldwide. He would definitely stay away from Lindt und Sprungli.
For daily updates, subscribe to our newsletter and for detailed information, reach out to us at sales@alphavalue.eu
Subscribe to our blog
